170 related articles for article (PubMed ID: 37674885)
1. Body composition parameters correlate with the endoscopic severity in Crohn's disease patients treated with infliximab.
Tang W; Xie G; Li J; Tan W; Yi R; Yang L; Zhang L; Deng J; Zhang Y; Li K
Front Nutr; 2023; 10():1251448. PubMed ID: 37674885
[TBL] [Abstract][Full Text] [Related]
2. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging assessment of body composition parameters in Crohn's disease.
Labarthe G; Dolores M; Verdalle-Cazes M; Charpentier C; Roullee P; Dacher JN; Savoye G; Savoye-Collet C
Dig Liver Dis; 2020 Aug; 52(8):878-884. PubMed ID: 32622612
[TBL] [Abstract][Full Text] [Related]
4. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
[TBL] [Abstract][Full Text] [Related]
5. Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn's disease under infliximab therapy.
Cao WT; Huang R; Liu S; Fan YH; Xu MS; Xu Y; Ni H
World J Gastroenterol; 2022 Jun; 28(23):2582-2596. PubMed ID: 35949356
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease.
Grillot J; D'Engremont C; Parmentier AL; Lakkis Z; Piton G; Cazaux D; Gay C; De Billy M; Koch S; Borot S; Vuitton L
Clin Nutr; 2020 Oct; 39(10):3024-3030. PubMed ID: 31980183
[TBL] [Abstract][Full Text] [Related]
7. Serial Changes in Body Composition and the Association with Disease Activity during Treatment in Patients with Crohn's Disease.
Lee JY; Kim KW; Ko Y; Oh CH; Kim BH; Park SJ; You MW
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428862
[TBL] [Abstract][Full Text] [Related]
8. Role of Human Body Composition Analysis and Malnutrition Risk Questionnaire in the Assessment of Nutritional Status of Patients With Initially Diagnosed Crohn's Disease.
Kurban M; Zeng N; Wang M; Liu H; Wu JR; Feng G; Liu M; Guo Q
Front Med (Lausanne); 2020; 7():106. PubMed ID: 32328493
[No Abstract] [Full Text] [Related]
9. Lower Subcutaneous or Visceral Adiposity Assessed by Abdominal Computed Tomography Could Predict Adverse Outcome in Patients With Crohn's Disease.
Thiberge C; Charpentier C; Gillibert A; Modzelewski R; Dacher JN; Savoye G; Savoye-Collet C
J Crohns Colitis; 2018 Nov; 12(12):1429-1437. PubMed ID: 30260374
[TBL] [Abstract][Full Text] [Related]
10. Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer.
Lin GT; Huang JB; Lin JL; Lin JX; Xie JW; Wang JB; Lu J; Zheng CH; Huang CM; Li P
Front Immunol; 2022; 13():1061044. PubMed ID: 36569876
[TBL] [Abstract][Full Text] [Related]
11. Correlation Among Body Composition Parameters and Long-Term Outcomes in Crohn's Disease After Anti-TNF Therapy.
Ando K; Uehara K; Sugiyama Y; Kobayashi Y; Murakami Y; Sato H; Kunogi T; Sasaki T; Takahashi K; Ueno N; Kashima S; Moriichi K; Tanabe H; Okumura T; Fujiya M
Front Nutr; 2022; 9():765209. PubMed ID: 35433773
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging-based body composition is associated with nutritional and inflammatory status: a longitudinal study in patients with Crohn's disease.
Zhou Z; Xiong Z; Shen Y; Li Z; Hu X; Hu D
Insights Imaging; 2021 Dec; 12(1):178. PubMed ID: 34862942
[TBL] [Abstract][Full Text] [Related]
14. Parameters of body composition and creeping fat are associated with activity of Crohn's disease.
Barajas Ordonez F; Melekh B; Rodríguez-Feria P; Damm R; Thormann M; March C; Omari J; Pech M; Surov A
Magn Reson Imaging; 2023 May; 98():1-6. PubMed ID: 36634829
[TBL] [Abstract][Full Text] [Related]
15. [Association between drug trough concentration and disease outcome before infliximab maintenance treatment in children with Crohn's disease].
Deng X; Yu Y; Wang XQ; Li J; Xu X; Xu CD; Xiao Y
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Nov; 24(11):1246-1251. PubMed ID: 36398551
[TBL] [Abstract][Full Text] [Related]
16. Computed tomography-based multiple body composition parameters predict outcomes in Crohn's disease.
Zhou Z; Xiong Z; Xie Q; Xiao P; Zhang Q; Gu J; Li J; Hu D; Hu X; Shen Y; Li Z
Insights Imaging; 2021 Sep; 12(1):135. PubMed ID: 34564786
[TBL] [Abstract][Full Text] [Related]
17. [
Chen L; Zhong X; Li L; Li X; Liu Y; Guo C; Chen Y; Huang Z
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1360-1370. PubMed ID: 36631715
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between contrast-enhanced ultrasound parameters and Crohn's disease activity].
Zhang YY; Yuan T; Wang CW; Wang L; Zhang HJ; Wang YL
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):427-432. PubMed ID: 37032139
[No Abstract] [Full Text] [Related]
19. Lower skeletal muscle attenuation and high visceral fat index are associated with complicated disease in patients with Crohn's disease: An exploratory study.
Cravo ML; Velho S; Torres J; Costa Santos MP; Palmela C; Cruz R; Strecht J; Maio R; Baracos V
Clin Nutr ESPEN; 2017 Oct; 21():79-85. PubMed ID: 30014873
[TBL] [Abstract][Full Text] [Related]
20. Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse events.
Phuong A; Marquardt JP; O'Malley R; Holt SK; Laidlaw G; Eagle Z; Ngo S; Orcutt D; Schade GR; Lin DW; Schweizer MT; Yezefski T; Yu EY; Montgomery B; Grivas P; Fintelmann FJ; Psutka SP
Urol Oncol; 2022 Oct; 40(10):456.e19-456.e30. PubMed ID: 36028450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
